March 14, 2025

Apixaban Lowers Bleeding Risk in HIV Patients With AF

In a national cohort study, warfarin and rivaroxaban were associated with significantly higher bleeding risks compared to apixaban in older adults with HIV and atrial fibrillation, particularly those on antiretroviral therapy.

Conexiant

March 13, 2025

FDA Chief Counsel Resigns Two Days In

U.S. FDA's chief counsel resigns amidst controversy surrounding her appointment and connections to mifepristone during the Biden administration.

Reuters

March 13, 2025

SSBs Linked to Oral Cancer Risk

Longitudinal study finds women consuming sugar-sweetened beverages daily face nearly five times higher risk of oral cavity cancer, with increased risk observed even among nonsmokers and non-drinkers.

Conexiant

March 13, 2025

Nivolumab Plus Cabozantinib Continues to Show Superior Long-Term Outcomes in Advanced Renal Cell Carcinoma

The PD-1 inhibitor nivolumab plus the tyrosine kinase inhibitor cabozantinib continues to demonstrate a significant survival advantage over sunitinib alone in patients with previously untreated advanc...

The ASCO Post

March 12, 2025

Exercise Boosts Erectile Function in Prostate Cancer

New clinical trial demonstrates supervised resistance and aerobic exercise significantly improves sexual function, body composition, and physical strength in men following prostate cancer treatment.

Conexiant

March 12, 2025

MRI Shows Persistent Gut Dysfunction in Celiac Despite Gluten-Free Diet

MRI findings show persistent gut motility and microbiome alterations in celiac disease despite a gluten-free diet.

Conexiant

March 12, 2025

Blood Donation Reshapes Stem Cell Mutations

Researchers discover erythropoietin released after blood donation selectively favors specific DNMT3A mutations in stem cells, revealing how frequent donation creates evolutionary pressure that differs from cancer-associated pathways.

Conexiant

March 12, 2025

CT Scan Radiation: Variability, Risk, and Regulation

New Medicare rules mandate stricter CT scan radiation tracking to reduce exposure risks, standardize dosing, and improve patient safety.

KFF Health News

March 11, 2025

FDA's New Pulse Oximeter Guidance: Stricter Standards, Ongoing Challenges

The FDA's 2025 pulse oximetry guidance introduces stricter accuracy standards, larger study cohorts, and objective skin pigmentation assessment to address measurement bias in darker-skinned patients.

Conexiant